Country 2 Country 4 Cancer (C2C4C) 2024

The 2024 Country 2 Country 4 Cancer ride organised by Bristol Myers Squibb will feature more than 90 of the company's employees cycling in five European countries from 6-23rd September in support of the Union for International Cancer Control (UICC) and selected members to raise funds with the aim of accelerating the fight against cancer and facilitating a better life for cancer patients.

Germany Day 2 BMS Riders

For the 9th year, the 2024 edition of the Country 2 Country 4 Cancer (C2C4C) ride will feature more than 90 Bristol Myers Squibb employees riding in Germany, Switzerland, France, Spain and the United Kingdom for nearly 2,200 kilometres from 6-23 September.

The 18-day event involves six teams each cycling a three-day segment. This year we celebrate 11 years of C2C4C and riding for patients, a tradition that launched with the inaugural event taking place in the United States in 2014. Since 2016, nearly 540 Bristol Myers Squibb employees in Europe have raised more than $3.1 million million through the C2C4C ride.

In this 2024 edition, six teams will feature riders participating from 17 countries including Belgium, Czech Republic, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Norway, Poland, Romania, Spain, Sweden, Switzerland, United Kingdom and United States. The mission of C2C4C is to raise awareness for cancer research and European cancer organisations who are members of the UICC.

Who are the riders

The participants are novice riders who have committed themselves to five months of intensive training to complete their portion of the ride. Some are cancer survivors, others have witnessed the devastating impact of cancer on friends and family. All are dedicated Bristol Myers Squibb employees who are riding to help raise funds to fight against cancer by supporting European cancer organizations, who are members of the UICC.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

For more information about Bristol Myers Squibb, visit us at BMS.com or follow them on LinkedInTwitterYouTube, Facebook, and Instagram.

Why raise funds for cancer organisations

Cancer is among the leading causes of death worldwide. In 2022, there were 20 million new cases and 9.7 million cancer-related deaths worldwide, and the number of cases are expected to rise further in the coming decade.

This is why Bristol Myers Squibb chooses to support the UICC and its members in their mission to reduce the global cancer burden, promote greater equity, and ensure that cancer is a priority on the world health and development agenda. 

Encourage your colleagues, family and friends to donate as cancer affects us all. Each team rides and raises funds for members of the Union for International Control.

How to support the 2024 C2C4C ride

Click your country charity below to support and donate to a local cancer patient organisations. Donations are open as of 3 June 2024.

Segment 1

Country Team – Germany & Czech Republic

Route: Munich, Germany to Boudry, Switzerland

Ride date: Sept. 6-8 2024

UICC members supported: 

Segment 2

Country Team – Italy & Switzerland/Austria

Route: Boudry, Switzerland to Nimes, France

Ride date: Sept. 9-11 2024

UICC members supported: 

Segment 3

Country Team – Nordics

Route: Nimes, France to Girona, Spain

Ride date: Sept. 12-14 2024

UICC members supported: 

Segment 4

Country Team – Spain/Portugal & Romania

Route: Girona, Spain to Toulouse, France

Ride date: Sept. 15-17 2024

UICC members supported: 

Segment 5

Country Team – France & Poland

Route: Toulouse, France to Paris, France

Ride date: Sept. 18-20 2024

UICC members supported: 

Segment 6

Country Team – United Kingdom/Ireland & Benelux

Route: Paris, France to London, United Kingdom

Ride date: Sept. 21-23 2024

UICC members supported: 

Quotes

“Many of us have been personally touched by cancer, the C2C4C ride binds us together to work as a team in memory of our friends, family and the many cancer patients out there we strive to help every day through our work. I am in awe of how much this initiative means to us all on a deep level. I wanted to participate this year to play my part in raising money for UICC's members to support patients in getting the diagnosis, treatment and care they need to combat cancer.”
“This year’s edition of Country 2 Country 4 Cancer is an occasion to celebrate 11 years of this fundraising adventure. UICC has been with Bristol Myers Squibb for most of this incredible journey, and we are very grateful on behalf of our members for the company’s generosity in supporting cancer research and people living with cancer. We are looking forward to this year’s ride!”
Dr Cary Adams

Past editions

Commemorating a decade of Bristol Myers Squibb employees cycling for cancer research

Group of cyclists on a road through a corn field, with t-shirts featuring Bristol Myers Squibb (BMS) and the Country 2 Country 4 Cancer ride
Read more

More epic cycling rides in 2022 by BMS to fundraise for UICC members

Employees of Bristol Myers Squibb riding for the Ger Power Irish team in the 2021 Country to Country for Cancer ride
Read more

Inside look at a record fundraise for the 2021 C2C4C ride

C2C4C ride - Netherland team in a huddle
Read more

Continued support for UICC members despite C2C4C cancellation

© Bristol-Myers Squibb | C2C4C ride
Read more

Bristol-Myers Squibb team completes fundraising ride across Europe

2019 C2C4C riders arrive at Bristol-Myers Squibb office in London, UK on 27 Sept. 2019
Read more

95 Bristol-Myers Squibb cyclists set off on a 3,600km journey across Europe for cancer research

C2C4C bikers cheering
Read more

Bristol-Myers Squibb Employees Cycle for Cancer Research

By:
Zach Stowlow
Read more

Bristol-Myers Squibb employees rode over 3,600 km across Europe for cancer patients

C2C4C - Bristol-Myers Squibb
Read more

Bristol-Myers Squibb employees raise funds for UICC members

© Bristol-Myers Squibb | C2C4C ride
Read more

Last update

Friday 31 May 2024

Share this page